Shares of MedEquities Realty Trust Inc. (NYSE:MRT) have received an average rating of “Buy” from the eight research firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and five have given a buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $12.67.

Separately, Zacks Investment Research raised shares of MedEquities Realty Trust from a “sell” rating to a “hold” rating in a research note on Wednesday, July 19th.

MedEquities Realty Trust (NYSE MRT) traded up 0.17% during mid-day trading on Tuesday, hitting $11.91. 77,807 shares of the stock traded hands. The company has a market cap of $378.43 million and a P/E ratio of 458.08. MedEquities Realty Trust has a 12 month low of $10.28 and a 12 month high of $13.06. The company’s 50 day moving average is $12.37 and its 200 day moving average is $11.70.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, August 30th. Investors of record on Wednesday, August 16th will be paid a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 7.05%. The ex-dividend date is Monday, August 14th.

TRADEMARK VIOLATION WARNING: “MedEquities Realty Trust Inc. (MRT) Receives Average Rating of “Buy” from Analysts” was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this story on another publication, it was stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/08/08/medequities-realty-trust-inc-mrt-receives-average-rating-of-buy-from-analysts.html.

Large investors have recently made changes to their positions in the stock. Stevens Capital Management LP purchased a new stake in shares of MedEquities Realty Trust during the first quarter valued at $113,000. Dynamic Technology Lab Private Ltd purchased a new stake in shares of MedEquities Realty Trust during the first quarter valued at $150,000. UBS Group AG increased its stake in shares of MedEquities Realty Trust by 190.0% in the first quarter. UBS Group AG now owns 13,504 shares of the financial services provider’s stock valued at $151,000 after buying an additional 8,847 shares in the last quarter. Eqis Capital Management Inc. purchased a new stake in shares of MedEquities Realty Trust during the second quarter valued at $153,000. Finally, Acadian Asset Management LLC purchased a new stake in shares of MedEquities Realty Trust during the second quarter valued at $175,000. 95.18% of the stock is currently owned by institutional investors and hedge funds.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.